MCEWEN INC (MUX.CA) Stock Fundamental Analysis

TSX:MUX • US58039P3055

34.98 CAD
-3.89 (-10.01%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, MUX scores 3 out of 10 in our fundamental rating. MUX was compared to 816 industry peers in the Metals & Mining industry. MUX may be in some trouble as it scores bad on both profitability and health. MUX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • MUX had negative earnings in the past year.
  • In the past year MUX had a positive cash flow from operations.
  • MUX had negative earnings in 4 of the past 5 years.
  • MUX had negative operating cash flow in 4 of the past 5 years.
MUX.CA Yearly Net Income VS EBIT VS OCF VS FCFMUX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.59%, MUX belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
  • MUX has a Return On Equity of -2.44%. This is amongst the best in the industry. MUX outperforms 80.64% of its industry peers.
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX.CA Yearly ROA, ROE, ROICMUX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

  • MUX's Gross Margin of 18.34% is amongst the best of the industry. MUX outperforms 87.62% of its industry peers.
  • In the last couple of years the Gross Margin of MUX has grown nicely.
  • The Profit Margin and Operating Margin are not available for MUX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX.CA Yearly Profit, Operating, Gross MarginsMUX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MUX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MUX has more shares outstanding
  • The debt/assets ratio for MUX has been reduced compared to a year ago.
MUX.CA Yearly Shares OutstandingMUX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX.CA Yearly Total Debt VS Total AssetsMUX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.71, we must say that MUX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.71, MUX perfoms like the industry average, outperforming 43.50% of the companies in the same industry.
  • A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.
  • MUX's Debt to Equity ratio of 0.26 is on the low side compared to the rest of the industry. MUX is outperformed by 68.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACCN/A
WACC10.09%
MUX.CA Yearly LT Debt VS Equity VS FCFMUX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • MUX has a Current Ratio of 2.10. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.
  • MUX's Current ratio of 2.10 is in line compared to the rest of the industry. MUX outperforms 52.08% of its industry peers.
  • MUX has a Quick Ratio of 1.58. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.58, MUX perfoms like the industry average, outperforming 49.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.58
MUX.CA Yearly Current Assets VS Current LiabilitesMUX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.80% over the past year.
  • The Revenue for MUX has decreased by -16.62% in the past year. This is quite bad
  • The Revenue has been growing by 8.32% on average over the past years. This is quite good.
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%

3.2 Future

  • Based on estimates for the next years, MUX will show a very strong growth in Earnings Per Share. The EPS will grow by 105.38% on average per year.
  • MUX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.50% yearly.
EPS Next Y104.89%
EPS Next 2Y114.12%
EPS Next 3Y105.38%
EPS Next 5YN/A
Revenue Next Year-11.27%
Revenue Next 2Y13.43%
Revenue Next 3Y9.5%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MUX.CA Yearly Revenue VS EstimatesMUX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MUX.CA Yearly EPS VS EstimatesMUX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 15.97, MUX is valued correctly.
  • Based on the Price/Forward Earnings ratio, MUX is valued cheaply inside the industry as 91.18% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.95. MUX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 15.97
MUX.CA Price Earnings VS Forward Price EarningsMUX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • 88.48% of the companies in the same industry are more expensive than MUX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 145.3
MUX.CA Per share dataMUX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MUX's earnings are expected to grow with 105.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.12%
EPS Next 3Y105.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MUX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MCEWEN INC

TSX:MUX (3/3/2026, 7:00:00 PM)

34.98

-3.89 (-10.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-05
Earnings (Next)03-12
Inst Owners45.87%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner ChangeN/A
Market Cap2.08B
Revenue(TTM)166.45M
Net Income(TTM)-11.92M
Analysts80
Price Target38.22 (9.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)193.94%
Min EPS beat(2)-106.19%
Max EPS beat(2)494.06%
EPS beat(4)1
Avg EPS beat(4)46.88%
Min EPS beat(4)-197.03%
Max EPS beat(4)494.06%
EPS beat(8)3
Avg EPS beat(8)8.28%
EPS beat(12)5
Avg EPS beat(12)-40.66%
EPS beat(16)6
Avg EPS beat(16)-62.37%
Revenue beat(2)0
Avg Revenue beat(2)-13.91%
Min Revenue beat(2)-22.09%
Max Revenue beat(2)-5.74%
Revenue beat(4)1
Avg Revenue beat(4)-8.56%
Min Revenue beat(4)-22.09%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)-3.06%
Revenue beat(16)6
Avg Revenue beat(16)-5.73%
PT rev (1m)19.27%
PT rev (3m)15.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.38%
EPS NY rev (1m)9.09%
EPS NY rev (3m)-92.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.03%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-8.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.97
P/S 9.14
P/FCF N/A
P/OCF 596.61
P/B 3.11
P/tB 3.11
EV/EBITDA 145.3
EPS(TTM)-0.46
EYN/A
EPS(NY)2.19
Fwd EY6.26%
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)0.06
OCFY0.17%
SpS3.83
BVpS11.24
TBVpS11.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.34%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 10.66
Cap/Depr 181.37%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 21.58%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.58
Altman-Z 1.71
F-Score4
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y104.89%
EPS Next 2Y114.12%
EPS Next 3Y105.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%
Revenue Next Year-11.27%
Revenue Next 2Y13.43%
Revenue Next 3Y9.5%
Revenue Next 5YN/A
EBIT growth 1Y-1953.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.49%
EBIT Next 3Y118.43%
EBIT Next 5YN/A
FCF growth 1Y57.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.9%
OCF growth 3YN/A
OCF growth 5YN/A

MCEWEN INC / MUX.CA FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MUX.CA.


What is the valuation status of MCEWEN INC (MUX.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX.CA). This can be considered as Fairly Valued.


What is the profitability of MUX stock?

MCEWEN INC (MUX.CA) has a profitability rating of 3 / 10.


What is the financial health of MCEWEN INC (MUX.CA) stock?

The financial health rating of MCEWEN INC (MUX.CA) is 3 / 10.